Global Multicancer Detection Supply, Demand and Key Producers, 2023-2029
The global Multicancer Detection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Multicancer Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multicancer Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multicancer Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Multicancer Detection total market, 2018-2029, (USD Million)
Global Multicancer Detection total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Multicancer Detection total market, key domestic companies and share, (USD Million)
Global Multicancer Detection revenue by player and market share 2018-2023, (USD Million)
Global Multicancer Detection total market by Type, CAGR, 2018-2029, (USD Million)
Global Multicancer Detection total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Multicancer Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Atara Biotherapeutics, Inc., Burning Rock DX, Danaher Corporation, Exact Sciences Corporation, Hoffmann-La Roche Ltd, Fulgent Genetics., Genecast Biotechnology Co., Ltd and Guardant Health, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multicancer Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Multicancer Detection Market, By Region:
1. How big is the global Multicancer Detection market?
2. What is the demand of the global Multicancer Detection market?
3. What is the year over year growth of the global Multicancer Detection market?
4. What is the total value of the global Multicancer Detection market?
5. Who are the major players in the global Multicancer Detection market?
6. What are the growth factors driving the market demand?
This report studies the global Multicancer Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multicancer Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multicancer Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Multicancer Detection total market, 2018-2029, (USD Million)
Global Multicancer Detection total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Multicancer Detection total market, key domestic companies and share, (USD Million)
Global Multicancer Detection revenue by player and market share 2018-2023, (USD Million)
Global Multicancer Detection total market by Type, CAGR, 2018-2029, (USD Million)
Global Multicancer Detection total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Multicancer Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Atara Biotherapeutics, Inc., Burning Rock DX, Danaher Corporation, Exact Sciences Corporation, Hoffmann-La Roche Ltd, Fulgent Genetics., Genecast Biotechnology Co., Ltd and Guardant Health, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multicancer Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Multicancer Detection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Laboratory Developed Tests (LDTs)
- In-Vitro Diagnostics (IVDs)
- Hospital
- Clinic
- Agilent Technologies, Inc.
- Atara Biotherapeutics, Inc.
- Burning Rock DX
- Danaher Corporation
- Exact Sciences Corporation
- Hoffmann-La Roche Ltd
- Fulgent Genetics.
- Genecast Biotechnology Co., Ltd
- Guardant Health, Inc.
- Illumina, Inc.
- Konica Minolta, Inc.
- Laboratory Corporation of America Holdings.
- Myriad Genetics, Inc.
- Tempus
- Thermo Fisher Scientific Inc.
1. How big is the global Multicancer Detection market?
2. What is the demand of the global Multicancer Detection market?
3. What is the year over year growth of the global Multicancer Detection market?
4. What is the total value of the global Multicancer Detection market?
5. Who are the major players in the global Multicancer Detection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Multicancer Detection Introduction
1.2 World Multicancer Detection Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Multicancer Detection Total Market by Region (by Headquarter Location)
1.3.1 World Multicancer Detection Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Multicancer Detection Market Size (2018-2029)
1.3.3 China Multicancer Detection Market Size (2018-2029)
1.3.4 Europe Multicancer Detection Market Size (2018-2029)
1.3.5 Japan Multicancer Detection Market Size (2018-2029)
1.3.6 South Korea Multicancer Detection Market Size (2018-2029)
1.3.7 ASEAN Multicancer Detection Market Size (2018-2029)
1.3.8 India Multicancer Detection Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Multicancer Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Multicancer Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Multicancer Detection Consumption Value (2018-2029)
2.2 World Multicancer Detection Consumption Value by Region
2.2.1 World Multicancer Detection Consumption Value by Region (2018-2023)
2.2.2 World Multicancer Detection Consumption Value Forecast by Region (2024-2029)
2.3 United States Multicancer Detection Consumption Value (2018-2029)
2.4 China Multicancer Detection Consumption Value (2018-2029)
2.5 Europe Multicancer Detection Consumption Value (2018-2029)
2.6 Japan Multicancer Detection Consumption Value (2018-2029)
2.7 South Korea Multicancer Detection Consumption Value (2018-2029)
2.8 ASEAN Multicancer Detection Consumption Value (2018-2029)
2.9 India Multicancer Detection Consumption Value (2018-2029)
3 WORLD MULTICANCER DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Multicancer Detection Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Multicancer Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Multicancer Detection in 2022
3.2.3 Global Concentration Ratios (CR8) for Multicancer Detection in 2022
3.3 Multicancer Detection Company Evaluation Quadrant
3.4 Multicancer Detection Market: Overall Company Footprint Analysis
3.4.1 Multicancer Detection Market: Region Footprint
3.4.2 Multicancer Detection Market: Company Product Type Footprint
3.4.3 Multicancer Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Multicancer Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Multicancer Detection Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Multicancer Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Multicancer Detection Consumption Value Comparison
4.2.1 United States VS China: Multicancer Detection Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Multicancer Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Multicancer Detection Companies and Market Share, 2018-2023
4.3.1 United States Based Multicancer Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Multicancer Detection Revenue, (2018-2023)
4.4 China Based Companies Multicancer Detection Revenue and Market Share, 2018-2023
4.4.1 China Based Multicancer Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Multicancer Detection Revenue, (2018-2023)
4.5 Rest of World Based Multicancer Detection Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Multicancer Detection Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Multicancer Detection Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Multicancer Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Laboratory Developed Tests (LDTs)
5.2.2 In-Vitro Diagnostics (IVDs)
5.3 Market Segment by Type
5.3.1 World Multicancer Detection Market Size by Type (2018-2023)
5.3.2 World Multicancer Detection Market Size by Type (2024-2029)
5.3.3 World Multicancer Detection Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Multicancer Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Multicancer Detection Market Size by Application (2018-2023)
6.3.2 World Multicancer Detection Market Size by Application (2024-2029)
6.3.3 World Multicancer Detection Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Details
7.1.2 Agilent Technologies, Inc. Major Business
7.1.3 Agilent Technologies, Inc. Multicancer Detection Product and Services
7.1.4 Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Technologies, Inc. Recent Developments/Updates
7.1.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
7.2 Atara Biotherapeutics, Inc.
7.2.1 Atara Biotherapeutics, Inc. Details
7.2.2 Atara Biotherapeutics, Inc. Major Business
7.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Product and Services
7.2.4 Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Atara Biotherapeutics, Inc. Recent Developments/Updates
7.2.6 Atara Biotherapeutics, Inc. Competitive Strengths & Weaknesses
7.3 Burning Rock DX
7.3.1 Burning Rock DX Details
7.3.2 Burning Rock DX Major Business
7.3.3 Burning Rock DX Multicancer Detection Product and Services
7.3.4 Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Burning Rock DX Recent Developments/Updates
7.3.6 Burning Rock DX Competitive Strengths & Weaknesses
7.4 Danaher Corporation
7.4.1 Danaher Corporation Details
7.4.2 Danaher Corporation Major Business
7.4.3 Danaher Corporation Multicancer Detection Product and Services
7.4.4 Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Danaher Corporation Recent Developments/Updates
7.4.6 Danaher Corporation Competitive Strengths & Weaknesses
7.5 Exact Sciences Corporation
7.5.1 Exact Sciences Corporation Details
7.5.2 Exact Sciences Corporation Major Business
7.5.3 Exact Sciences Corporation Multicancer Detection Product and Services
7.5.4 Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Exact Sciences Corporation Recent Developments/Updates
7.5.6 Exact Sciences Corporation Competitive Strengths & Weaknesses
7.6 Hoffmann-La Roche Ltd
7.6.1 Hoffmann-La Roche Ltd Details
7.6.2 Hoffmann-La Roche Ltd Major Business
7.6.3 Hoffmann-La Roche Ltd Multicancer Detection Product and Services
7.6.4 Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Hoffmann-La Roche Ltd Recent Developments/Updates
7.6.6 Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.7 Fulgent Genetics.
7.7.1 Fulgent Genetics. Details
7.7.2 Fulgent Genetics. Major Business
7.7.3 Fulgent Genetics. Multicancer Detection Product and Services
7.7.4 Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Fulgent Genetics. Recent Developments/Updates
7.7.6 Fulgent Genetics. Competitive Strengths & Weaknesses
7.8 Genecast Biotechnology Co., Ltd
7.8.1 Genecast Biotechnology Co., Ltd Details
7.8.2 Genecast Biotechnology Co., Ltd Major Business
7.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Product and Services
7.8.4 Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Genecast Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Genecast Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Guardant Health, Inc.
7.9.1 Guardant Health, Inc. Details
7.9.2 Guardant Health, Inc. Major Business
7.9.3 Guardant Health, Inc. Multicancer Detection Product and Services
7.9.4 Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Guardant Health, Inc. Recent Developments/Updates
7.9.6 Guardant Health, Inc. Competitive Strengths & Weaknesses
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Details
7.10.2 Illumina, Inc. Major Business
7.10.3 Illumina, Inc. Multicancer Detection Product and Services
7.10.4 Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Illumina, Inc. Recent Developments/Updates
7.10.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.11 Konica Minolta, Inc.
7.11.1 Konica Minolta, Inc. Details
7.11.2 Konica Minolta, Inc. Major Business
7.11.3 Konica Minolta, Inc. Multicancer Detection Product and Services
7.11.4 Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Konica Minolta, Inc. Recent Developments/Updates
7.11.6 Konica Minolta, Inc. Competitive Strengths & Weaknesses
7.12 Laboratory Corporation of America Holdings.
7.12.1 Laboratory Corporation of America Holdings. Details
7.12.2 Laboratory Corporation of America Holdings. Major Business
7.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Product and Services
7.12.4 Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Laboratory Corporation of America Holdings. Recent Developments/Updates
7.12.6 Laboratory Corporation of America Holdings. Competitive Strengths & Weaknesses
7.13 Myriad Genetics, Inc.
7.13.1 Myriad Genetics, Inc. Details
7.13.2 Myriad Genetics, Inc. Major Business
7.13.3 Myriad Genetics, Inc. Multicancer Detection Product and Services
7.13.4 Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Myriad Genetics, Inc. Recent Developments/Updates
7.13.6 Myriad Genetics, Inc. Competitive Strengths & Weaknesses
7.14 Tempus
7.14.1 Tempus Details
7.14.2 Tempus Major Business
7.14.3 Tempus Multicancer Detection Product and Services
7.14.4 Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Tempus Recent Developments/Updates
7.14.6 Tempus Competitive Strengths & Weaknesses
7.15 Thermo Fisher Scientific Inc.
7.15.1 Thermo Fisher Scientific Inc. Details
7.15.2 Thermo Fisher Scientific Inc. Major Business
7.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Product and Services
7.15.4 Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.15.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Multicancer Detection Industry Chain
8.2 Multicancer Detection Upstream Analysis
8.3 Multicancer Detection Midstream Analysis
8.4 Multicancer Detection Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Multicancer Detection Introduction
1.2 World Multicancer Detection Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Multicancer Detection Total Market by Region (by Headquarter Location)
1.3.1 World Multicancer Detection Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Multicancer Detection Market Size (2018-2029)
1.3.3 China Multicancer Detection Market Size (2018-2029)
1.3.4 Europe Multicancer Detection Market Size (2018-2029)
1.3.5 Japan Multicancer Detection Market Size (2018-2029)
1.3.6 South Korea Multicancer Detection Market Size (2018-2029)
1.3.7 ASEAN Multicancer Detection Market Size (2018-2029)
1.3.8 India Multicancer Detection Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Multicancer Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Multicancer Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Multicancer Detection Consumption Value (2018-2029)
2.2 World Multicancer Detection Consumption Value by Region
2.2.1 World Multicancer Detection Consumption Value by Region (2018-2023)
2.2.2 World Multicancer Detection Consumption Value Forecast by Region (2024-2029)
2.3 United States Multicancer Detection Consumption Value (2018-2029)
2.4 China Multicancer Detection Consumption Value (2018-2029)
2.5 Europe Multicancer Detection Consumption Value (2018-2029)
2.6 Japan Multicancer Detection Consumption Value (2018-2029)
2.7 South Korea Multicancer Detection Consumption Value (2018-2029)
2.8 ASEAN Multicancer Detection Consumption Value (2018-2029)
2.9 India Multicancer Detection Consumption Value (2018-2029)
3 WORLD MULTICANCER DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Multicancer Detection Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Multicancer Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Multicancer Detection in 2022
3.2.3 Global Concentration Ratios (CR8) for Multicancer Detection in 2022
3.3 Multicancer Detection Company Evaluation Quadrant
3.4 Multicancer Detection Market: Overall Company Footprint Analysis
3.4.1 Multicancer Detection Market: Region Footprint
3.4.2 Multicancer Detection Market: Company Product Type Footprint
3.4.3 Multicancer Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Multicancer Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Multicancer Detection Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Multicancer Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Multicancer Detection Consumption Value Comparison
4.2.1 United States VS China: Multicancer Detection Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Multicancer Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Multicancer Detection Companies and Market Share, 2018-2023
4.3.1 United States Based Multicancer Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Multicancer Detection Revenue, (2018-2023)
4.4 China Based Companies Multicancer Detection Revenue and Market Share, 2018-2023
4.4.1 China Based Multicancer Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Multicancer Detection Revenue, (2018-2023)
4.5 Rest of World Based Multicancer Detection Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Multicancer Detection Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Multicancer Detection Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Multicancer Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Laboratory Developed Tests (LDTs)
5.2.2 In-Vitro Diagnostics (IVDs)
5.3 Market Segment by Type
5.3.1 World Multicancer Detection Market Size by Type (2018-2023)
5.3.2 World Multicancer Detection Market Size by Type (2024-2029)
5.3.3 World Multicancer Detection Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Multicancer Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Multicancer Detection Market Size by Application (2018-2023)
6.3.2 World Multicancer Detection Market Size by Application (2024-2029)
6.3.3 World Multicancer Detection Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Details
7.1.2 Agilent Technologies, Inc. Major Business
7.1.3 Agilent Technologies, Inc. Multicancer Detection Product and Services
7.1.4 Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Technologies, Inc. Recent Developments/Updates
7.1.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
7.2 Atara Biotherapeutics, Inc.
7.2.1 Atara Biotherapeutics, Inc. Details
7.2.2 Atara Biotherapeutics, Inc. Major Business
7.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Product and Services
7.2.4 Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Atara Biotherapeutics, Inc. Recent Developments/Updates
7.2.6 Atara Biotherapeutics, Inc. Competitive Strengths & Weaknesses
7.3 Burning Rock DX
7.3.1 Burning Rock DX Details
7.3.2 Burning Rock DX Major Business
7.3.3 Burning Rock DX Multicancer Detection Product and Services
7.3.4 Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Burning Rock DX Recent Developments/Updates
7.3.6 Burning Rock DX Competitive Strengths & Weaknesses
7.4 Danaher Corporation
7.4.1 Danaher Corporation Details
7.4.2 Danaher Corporation Major Business
7.4.3 Danaher Corporation Multicancer Detection Product and Services
7.4.4 Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Danaher Corporation Recent Developments/Updates
7.4.6 Danaher Corporation Competitive Strengths & Weaknesses
7.5 Exact Sciences Corporation
7.5.1 Exact Sciences Corporation Details
7.5.2 Exact Sciences Corporation Major Business
7.5.3 Exact Sciences Corporation Multicancer Detection Product and Services
7.5.4 Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Exact Sciences Corporation Recent Developments/Updates
7.5.6 Exact Sciences Corporation Competitive Strengths & Weaknesses
7.6 Hoffmann-La Roche Ltd
7.6.1 Hoffmann-La Roche Ltd Details
7.6.2 Hoffmann-La Roche Ltd Major Business
7.6.3 Hoffmann-La Roche Ltd Multicancer Detection Product and Services
7.6.4 Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Hoffmann-La Roche Ltd Recent Developments/Updates
7.6.6 Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.7 Fulgent Genetics.
7.7.1 Fulgent Genetics. Details
7.7.2 Fulgent Genetics. Major Business
7.7.3 Fulgent Genetics. Multicancer Detection Product and Services
7.7.4 Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Fulgent Genetics. Recent Developments/Updates
7.7.6 Fulgent Genetics. Competitive Strengths & Weaknesses
7.8 Genecast Biotechnology Co., Ltd
7.8.1 Genecast Biotechnology Co., Ltd Details
7.8.2 Genecast Biotechnology Co., Ltd Major Business
7.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Product and Services
7.8.4 Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Genecast Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Genecast Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Guardant Health, Inc.
7.9.1 Guardant Health, Inc. Details
7.9.2 Guardant Health, Inc. Major Business
7.9.3 Guardant Health, Inc. Multicancer Detection Product and Services
7.9.4 Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Guardant Health, Inc. Recent Developments/Updates
7.9.6 Guardant Health, Inc. Competitive Strengths & Weaknesses
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Details
7.10.2 Illumina, Inc. Major Business
7.10.3 Illumina, Inc. Multicancer Detection Product and Services
7.10.4 Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Illumina, Inc. Recent Developments/Updates
7.10.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.11 Konica Minolta, Inc.
7.11.1 Konica Minolta, Inc. Details
7.11.2 Konica Minolta, Inc. Major Business
7.11.3 Konica Minolta, Inc. Multicancer Detection Product and Services
7.11.4 Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Konica Minolta, Inc. Recent Developments/Updates
7.11.6 Konica Minolta, Inc. Competitive Strengths & Weaknesses
7.12 Laboratory Corporation of America Holdings.
7.12.1 Laboratory Corporation of America Holdings. Details
7.12.2 Laboratory Corporation of America Holdings. Major Business
7.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Product and Services
7.12.4 Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Laboratory Corporation of America Holdings. Recent Developments/Updates
7.12.6 Laboratory Corporation of America Holdings. Competitive Strengths & Weaknesses
7.13 Myriad Genetics, Inc.
7.13.1 Myriad Genetics, Inc. Details
7.13.2 Myriad Genetics, Inc. Major Business
7.13.3 Myriad Genetics, Inc. Multicancer Detection Product and Services
7.13.4 Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Myriad Genetics, Inc. Recent Developments/Updates
7.13.6 Myriad Genetics, Inc. Competitive Strengths & Weaknesses
7.14 Tempus
7.14.1 Tempus Details
7.14.2 Tempus Major Business
7.14.3 Tempus Multicancer Detection Product and Services
7.14.4 Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Tempus Recent Developments/Updates
7.14.6 Tempus Competitive Strengths & Weaknesses
7.15 Thermo Fisher Scientific Inc.
7.15.1 Thermo Fisher Scientific Inc. Details
7.15.2 Thermo Fisher Scientific Inc. Major Business
7.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Product and Services
7.15.4 Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.15.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Multicancer Detection Industry Chain
8.2 Multicancer Detection Upstream Analysis
8.3 Multicancer Detection Midstream Analysis
8.4 Multicancer Detection Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Multicancer Detection Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Multicancer Detection Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Multicancer Detection Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Multicancer Detection Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Multicancer Detection Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Multicancer Detection Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Multicancer Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Multicancer Detection Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Multicancer Detection Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Multicancer Detection Players in 2022
Table 12. World Multicancer Detection Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Multicancer Detection Company Evaluation Quadrant
Table 14. Head Office of Key Multicancer Detection Player
Table 15. Multicancer Detection Market: Company Product Type Footprint
Table 16. Multicancer Detection Market: Company Product Application Footprint
Table 17. Multicancer Detection Mergers & Acquisitions Activity
Table 18. United States VS China Multicancer Detection Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Multicancer Detection Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Multicancer Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Multicancer Detection Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Multicancer Detection Revenue Market Share (2018-2023)
Table 23. China Based Multicancer Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Multicancer Detection Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Multicancer Detection Revenue Market Share (2018-2023)
Table 26. Rest of World Based Multicancer Detection Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Multicancer Detection Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Multicancer Detection Revenue Market Share (2018-2023)
Table 29. World Multicancer Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Multicancer Detection Market Size by Type (2018-2023) & (USD Million)
Table 31. World Multicancer Detection Market Size by Type (2024-2029) & (USD Million)
Table 32. World Multicancer Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Multicancer Detection Market Size by Application (2018-2023) & (USD Million)
Table 34. World Multicancer Detection Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
Table 36. Agilent Technologies, Inc. Major Business
Table 37. Agilent Technologies, Inc. Multicancer Detection Product and Services
Table 38. Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Technologies, Inc. Recent Developments/Updates
Table 40. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 41. Atara Biotherapeutics, Inc. Basic Information, Area Served and Competitors
Table 42. Atara Biotherapeutics, Inc. Major Business
Table 43. Atara Biotherapeutics, Inc. Multicancer Detection Product and Services
Table 44. Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Atara Biotherapeutics, Inc. Recent Developments/Updates
Table 46. Atara Biotherapeutics, Inc. Competitive Strengths & Weaknesses
Table 47. Burning Rock DX Basic Information, Area Served and Competitors
Table 48. Burning Rock DX Major Business
Table 49. Burning Rock DX Multicancer Detection Product and Services
Table 50. Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Burning Rock DX Recent Developments/Updates
Table 52. Burning Rock DX Competitive Strengths & Weaknesses
Table 53. Danaher Corporation Basic Information, Area Served and Competitors
Table 54. Danaher Corporation Major Business
Table 55. Danaher Corporation Multicancer Detection Product and Services
Table 56. Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Danaher Corporation Recent Developments/Updates
Table 58. Danaher Corporation Competitive Strengths & Weaknesses
Table 59. Exact Sciences Corporation Basic Information, Area Served and Competitors
Table 60. Exact Sciences Corporation Major Business
Table 61. Exact Sciences Corporation Multicancer Detection Product and Services
Table 62. Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Exact Sciences Corporation Recent Developments/Updates
Table 64. Exact Sciences Corporation Competitive Strengths & Weaknesses
Table 65. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
Table 66. Hoffmann-La Roche Ltd Major Business
Table 67. Hoffmann-La Roche Ltd Multicancer Detection Product and Services
Table 68. Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 70. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 71. Fulgent Genetics. Basic Information, Area Served and Competitors
Table 72. Fulgent Genetics. Major Business
Table 73. Fulgent Genetics. Multicancer Detection Product and Services
Table 74. Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Fulgent Genetics. Recent Developments/Updates
Table 76. Fulgent Genetics. Competitive Strengths & Weaknesses
Table 77. Genecast Biotechnology Co., Ltd Basic Information, Area Served and Competitors
Table 78. Genecast Biotechnology Co., Ltd Major Business
Table 79. Genecast Biotechnology Co., Ltd Multicancer Detection Product and Services
Table 80. Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Genecast Biotechnology Co., Ltd Recent Developments/Updates
Table 82. Genecast Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 83. Guardant Health, Inc. Basic Information, Area Served and Competitors
Table 84. Guardant Health, Inc. Major Business
Table 85. Guardant Health, Inc. Multicancer Detection Product and Services
Table 86. Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Guardant Health, Inc. Recent Developments/Updates
Table 88. Guardant Health, Inc. Competitive Strengths & Weaknesses
Table 89. Illumina, Inc. Basic Information, Area Served and Competitors
Table 90. Illumina, Inc. Major Business
Table 91. Illumina, Inc. Multicancer Detection Product and Services
Table 92. Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Illumina, Inc. Recent Developments/Updates
Table 94. Illumina, Inc. Competitive Strengths & Weaknesses
Table 95. Konica Minolta, Inc. Basic Information, Area Served and Competitors
Table 96. Konica Minolta, Inc. Major Business
Table 97. Konica Minolta, Inc. Multicancer Detection Product and Services
Table 98. Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Konica Minolta, Inc. Recent Developments/Updates
Table 100. Konica Minolta, Inc. Competitive Strengths & Weaknesses
Table 101. Laboratory Corporation of America Holdings. Basic Information, Area Served and Competitors
Table 102. Laboratory Corporation of America Holdings. Major Business
Table 103. Laboratory Corporation of America Holdings. Multicancer Detection Product and Services
Table 104. Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Laboratory Corporation of America Holdings. Recent Developments/Updates
Table 106. Laboratory Corporation of America Holdings. Competitive Strengths & Weaknesses
Table 107. Myriad Genetics, Inc. Basic Information, Area Served and Competitors
Table 108. Myriad Genetics, Inc. Major Business
Table 109. Myriad Genetics, Inc. Multicancer Detection Product and Services
Table 110. Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Myriad Genetics, Inc. Recent Developments/Updates
Table 112. Myriad Genetics, Inc. Competitive Strengths & Weaknesses
Table 113. Tempus Basic Information, Area Served and Competitors
Table 114. Tempus Major Business
Table 115. Tempus Multicancer Detection Product and Services
Table 116. Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Tempus Recent Developments/Updates
Table 118. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 119. Thermo Fisher Scientific Inc. Major Business
Table 120. Thermo Fisher Scientific Inc. Multicancer Detection Product and Services
Table 121. Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Multicancer Detection Upstream (Raw Materials)
Table 123. Multicancer Detection Typical Customers
Table 1. World Multicancer Detection Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Multicancer Detection Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Multicancer Detection Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Multicancer Detection Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Multicancer Detection Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Multicancer Detection Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Multicancer Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Multicancer Detection Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Multicancer Detection Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Multicancer Detection Players in 2022
Table 12. World Multicancer Detection Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Multicancer Detection Company Evaluation Quadrant
Table 14. Head Office of Key Multicancer Detection Player
Table 15. Multicancer Detection Market: Company Product Type Footprint
Table 16. Multicancer Detection Market: Company Product Application Footprint
Table 17. Multicancer Detection Mergers & Acquisitions Activity
Table 18. United States VS China Multicancer Detection Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Multicancer Detection Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Multicancer Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Multicancer Detection Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Multicancer Detection Revenue Market Share (2018-2023)
Table 23. China Based Multicancer Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Multicancer Detection Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Multicancer Detection Revenue Market Share (2018-2023)
Table 26. Rest of World Based Multicancer Detection Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Multicancer Detection Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Multicancer Detection Revenue Market Share (2018-2023)
Table 29. World Multicancer Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Multicancer Detection Market Size by Type (2018-2023) & (USD Million)
Table 31. World Multicancer Detection Market Size by Type (2024-2029) & (USD Million)
Table 32. World Multicancer Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Multicancer Detection Market Size by Application (2018-2023) & (USD Million)
Table 34. World Multicancer Detection Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
Table 36. Agilent Technologies, Inc. Major Business
Table 37. Agilent Technologies, Inc. Multicancer Detection Product and Services
Table 38. Agilent Technologies, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Technologies, Inc. Recent Developments/Updates
Table 40. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 41. Atara Biotherapeutics, Inc. Basic Information, Area Served and Competitors
Table 42. Atara Biotherapeutics, Inc. Major Business
Table 43. Atara Biotherapeutics, Inc. Multicancer Detection Product and Services
Table 44. Atara Biotherapeutics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Atara Biotherapeutics, Inc. Recent Developments/Updates
Table 46. Atara Biotherapeutics, Inc. Competitive Strengths & Weaknesses
Table 47. Burning Rock DX Basic Information, Area Served and Competitors
Table 48. Burning Rock DX Major Business
Table 49. Burning Rock DX Multicancer Detection Product and Services
Table 50. Burning Rock DX Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Burning Rock DX Recent Developments/Updates
Table 52. Burning Rock DX Competitive Strengths & Weaknesses
Table 53. Danaher Corporation Basic Information, Area Served and Competitors
Table 54. Danaher Corporation Major Business
Table 55. Danaher Corporation Multicancer Detection Product and Services
Table 56. Danaher Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Danaher Corporation Recent Developments/Updates
Table 58. Danaher Corporation Competitive Strengths & Weaknesses
Table 59. Exact Sciences Corporation Basic Information, Area Served and Competitors
Table 60. Exact Sciences Corporation Major Business
Table 61. Exact Sciences Corporation Multicancer Detection Product and Services
Table 62. Exact Sciences Corporation Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Exact Sciences Corporation Recent Developments/Updates
Table 64. Exact Sciences Corporation Competitive Strengths & Weaknesses
Table 65. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
Table 66. Hoffmann-La Roche Ltd Major Business
Table 67. Hoffmann-La Roche Ltd Multicancer Detection Product and Services
Table 68. Hoffmann-La Roche Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 70. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 71. Fulgent Genetics. Basic Information, Area Served and Competitors
Table 72. Fulgent Genetics. Major Business
Table 73. Fulgent Genetics. Multicancer Detection Product and Services
Table 74. Fulgent Genetics. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Fulgent Genetics. Recent Developments/Updates
Table 76. Fulgent Genetics. Competitive Strengths & Weaknesses
Table 77. Genecast Biotechnology Co., Ltd Basic Information, Area Served and Competitors
Table 78. Genecast Biotechnology Co., Ltd Major Business
Table 79. Genecast Biotechnology Co., Ltd Multicancer Detection Product and Services
Table 80. Genecast Biotechnology Co., Ltd Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Genecast Biotechnology Co., Ltd Recent Developments/Updates
Table 82. Genecast Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 83. Guardant Health, Inc. Basic Information, Area Served and Competitors
Table 84. Guardant Health, Inc. Major Business
Table 85. Guardant Health, Inc. Multicancer Detection Product and Services
Table 86. Guardant Health, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Guardant Health, Inc. Recent Developments/Updates
Table 88. Guardant Health, Inc. Competitive Strengths & Weaknesses
Table 89. Illumina, Inc. Basic Information, Area Served and Competitors
Table 90. Illumina, Inc. Major Business
Table 91. Illumina, Inc. Multicancer Detection Product and Services
Table 92. Illumina, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Illumina, Inc. Recent Developments/Updates
Table 94. Illumina, Inc. Competitive Strengths & Weaknesses
Table 95. Konica Minolta, Inc. Basic Information, Area Served and Competitors
Table 96. Konica Minolta, Inc. Major Business
Table 97. Konica Minolta, Inc. Multicancer Detection Product and Services
Table 98. Konica Minolta, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Konica Minolta, Inc. Recent Developments/Updates
Table 100. Konica Minolta, Inc. Competitive Strengths & Weaknesses
Table 101. Laboratory Corporation of America Holdings. Basic Information, Area Served and Competitors
Table 102. Laboratory Corporation of America Holdings. Major Business
Table 103. Laboratory Corporation of America Holdings. Multicancer Detection Product and Services
Table 104. Laboratory Corporation of America Holdings. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Laboratory Corporation of America Holdings. Recent Developments/Updates
Table 106. Laboratory Corporation of America Holdings. Competitive Strengths & Weaknesses
Table 107. Myriad Genetics, Inc. Basic Information, Area Served and Competitors
Table 108. Myriad Genetics, Inc. Major Business
Table 109. Myriad Genetics, Inc. Multicancer Detection Product and Services
Table 110. Myriad Genetics, Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Myriad Genetics, Inc. Recent Developments/Updates
Table 112. Myriad Genetics, Inc. Competitive Strengths & Weaknesses
Table 113. Tempus Basic Information, Area Served and Competitors
Table 114. Tempus Major Business
Table 115. Tempus Multicancer Detection Product and Services
Table 116. Tempus Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Tempus Recent Developments/Updates
Table 118. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
Table 119. Thermo Fisher Scientific Inc. Major Business
Table 120. Thermo Fisher Scientific Inc. Multicancer Detection Product and Services
Table 121. Thermo Fisher Scientific Inc. Multicancer Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Multicancer Detection Upstream (Raw Materials)
Table 123. Multicancer Detection Typical Customers
LIST OF FIGURES
Figure 1. Multicancer Detection Picture
Figure 2. World Multicancer Detection Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Multicancer Detection Total Market Size (2018-2029) & (USD Million)
Figure 4. World Multicancer Detection Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Multicancer Detection Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 13. Multicancer Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. World Multicancer Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. China Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. India Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Multicancer Detection by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Multicancer Detection Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Multicancer Detection Markets in 2022
Figure 27. United States VS China: Multicancer Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Multicancer Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Multicancer Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Multicancer Detection Market Size Market Share by Type in 2022
Figure 31. Laboratory Developed Tests (LDTs)
Figure 32. In-Vitro Diagnostics (IVDs)
Figure 33. World Multicancer Detection Market Size Market Share by Type (2018-2029)
Figure 34. World Multicancer Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Multicancer Detection Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Multicancer Detection Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Multicancer Detection Picture
Figure 2. World Multicancer Detection Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Multicancer Detection Total Market Size (2018-2029) & (USD Million)
Figure 4. World Multicancer Detection Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Multicancer Detection Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Multicancer Detection Revenue (2018-2029) & (USD Million)
Figure 13. Multicancer Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. World Multicancer Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. China Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. India Multicancer Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Multicancer Detection by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Multicancer Detection Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Multicancer Detection Markets in 2022
Figure 27. United States VS China: Multicancer Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Multicancer Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Multicancer Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Multicancer Detection Market Size Market Share by Type in 2022
Figure 31. Laboratory Developed Tests (LDTs)
Figure 32. In-Vitro Diagnostics (IVDs)
Figure 33. World Multicancer Detection Market Size Market Share by Type (2018-2029)
Figure 34. World Multicancer Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Multicancer Detection Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Multicancer Detection Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
